Cold chain technology deal

GE Healthcare has expanded its capacity for industralising cell therapies with the acquisition of Asymptote Ltd, a UK consultancy with technology for simplifying the freezing of cells intended as therapies, and thawing them before their use in patients.

Full text available to subscribers only. Click here for information on subscribing to MedNous.


United Kingdom